论文部分内容阅读
本研究目的是确定是否除胰岛细胞抗体 (ＩＣＡ)及胰岛素自身抗体 (ＩＡＡ)之外 ,谷氨酸脱羧酶 (ＧＡＤ)抗体测定可更好地区别那些进展为临床糖尿病的受试者与非进展者 ,并找出运用哪些 β细胞功能测定法可更好地预测临床糖尿病进展型。对象与方法 对 3 0 0 0多名 1型糖尿病人
The purpose of this study was to determine whether a glutamate decarboxylase (GAD) antibody assay could better distinguish between those with progression to clinical diabetes and non-progression other than islet cell antibodies (ICA) and insulin autoantibodies (IAA) And to find out which beta cell function assays to use to better predict the clinical progression of diabetes. Subjects and Methods More than 300 type 1 diabetic patients